H.R. 5950 · 117th Congress · House

Improving Patient Access to Care and Treatment Act

Active· Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Introduced
Nov 12, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Improving Patient Access to Care and Treatment Act

This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.

Action Timeline

6
  1. NOV 01, 2022•Committee

    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

  2. NOV 15, 2021•Committee

    Referred to the Subcommittee on Health.

  3. NOV 12, 2021•IntroReferral

    Introduced in House

  4. NOV 12, 2021•IntroReferral

    Introduced in House

  5. NOV 12, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. NOV 12, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

4

Crime and Federal Government Surveillance Subcommittee

hsju08

Referred: Nov 1, 2022

Active

Health Subcommittee

hsif14

Referred: Nov 16, 2021

Active

Judiciary Committee

hsju00

Referred: Nov 12, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Nov 12, 2021

Active